ライフサイエンスコーパス: MR spectroscopy

1 simultaneous imaging of both paws with (13)C MR spectroscopy.

2 in inflamed and control paws by using (13)C MR spectroscopy.

3 compared with more than 50% for uncorrected MR spectroscopy.

4 surement bias with conventional, uncorrected MR spectroscopy.

5 olution images, faster imaging, and improved MR spectroscopy.

6 tion of multiple fluorine signatures via 19F MR spectroscopy.

7 outcome group, P<5x10(-9)), as measured with MR spectroscopy.

8 ngle-voxel short-echo-time point-resolved 1H MR spectroscopy.

9 Cho) was quantified by using single-voxel 1H MR spectroscopy.

10 quantified by using single-voxel hydrogen 1 MR spectroscopy.

11 quantitatively studied noninvasively with 1H MR spectroscopy.

12 g magnetic resonance (MR) imaging and proton MR spectroscopy.

13 termine clinical utility of vertebral proton MR spectroscopy.

14 ctive magnetic resonance (MR) microscopy and MR spectroscopy.

15 axial-DSC perfusion followed by 3D-T1WI and MR spectroscopy.

16 lled long COVID, which can be assessed using MR spectroscopy.

17 volunteers underwent brain imaging including MR spectroscopy.

18 n Glx and Lac concentration were observed in MR spectroscopy.

19 sing in vivo single-voxel diffusion-weighted MR spectroscopy.

20 derwent extracellular pH mapping with use of MR spectroscopy.

21 reconstruction and, as a reference standard, MR spectroscopy.

22 neuronal injury have been demonstrated with MR spectroscopy.

23 nterior cingulate cortex were measured using MR spectroscopy.

24 been interrogated using hyperpolarized (13)C MR spectroscopy.

25 amic contrast agent-enhanced MR imaging, and MR spectroscopy.

26 ise as measured by (31)P magnetic resonance (MR) spectroscopy.

27 Proton MR spectroscopy ((1)H MRS) was used to divide MDD subjec

28 As proton MR spectroscopy ((1)H-MRS) can identify ischaemic tissue

29 Proton MR spectroscopy ((1)H-MRS) estimates of dACC levels of G

30 Proton MR spectroscopy ((1)H-MRS) has been used to assess regio

31 Proton MR spectroscopy ((1)H-MRS) studies of in vivo neurochemi

32 resonance (MR) techniques, including proton MR spectroscopy ((1)H-MRS), although the stage at which

33 ed regions had reduced 39K concentration (by MR spectroscopy, 40.5+/-9.3% of remote; P<0.001), reduce

34 brachii were measured from single-voxel (1)H MR spectroscopy (9000/11-243).

35 5%) of 20 benign lesions, giving proton (1H) MR spectroscopy a sensitivity of 100% (95% confidence in

36 s) and in three of 26 benign lesions, giving MR spectroscopy a sensitivity of 100% and a specificity

37 e results were confirmed by direct oxygen-17 MR spectroscopy, a gold standard for in vivo H(2)(17)O m

38 ginal diffusion-weighted magnetic resonance (MR) spectroscopy acquisition and novel modeling strategi

39 sion-weighted imaging, perfusion imaging and MR spectroscopy, additional quantitative metrics have be

40 irmed infarct-related reductions observed at MR spectroscopy, although high-energy phosphate concentr

41 test, and relationships between MRI and (1)H MR spectroscopy and arm function were assessed by using

42 ject age, subject sex, and time between (1)H MR spectroscopy and death.

43 MR spectroscopy and diffusion-based tractography of the

44 Multisection proton MR spectroscopy and DT imaging were performed in 11 pati

45 There was excellent agreement between (1)H MR spectroscopy and dual-energy CT, with a mean differen

46 f continuous theta burst stimulation (cTBS), MR spectroscopy and fMRI to investigate the role of GABA

47 spective cross-sectional study, MRI and (1)H MR spectroscopy and functional assessment data were acqu

48 Proof-of-principle in vivo MR spectroscopy and functional MRI experiments were also

49 6 years) gave informed consent and underwent MR spectroscopy and GRE MR imaging of the liver.

50 terobacteriaceae positively) correlated with MR spectroscopy and hyperammonemia-associated astrocytic

51 enzyme expression in live cells using (19) F MR spectroscopy and imaging that differentiate signals b

52 pH(i) was calculated using phosphorus-31 MR spectroscopy and lactate/creatine was measured using

53 MR spectroscopy and microinjections of cryoprotectants i

54 numerous different ways, most typically with MR spectroscopy and MR imaging.

55 s, 14 without risk factors) underwent proton MR spectroscopy and non-T1-weighted gradient-echo MR ima

56 Single-voxel proton MR spectroscopy and perfusion MR imaging were conducted

57 Twenty-eight patients underwent both MR spectroscopy and perfusion MR imaging.

58 latter was achieved by using localized (1)H MR spectroscopy and resting-state functional MRI (fMRI)

59 tween marrow fat fraction obtained with (1)H MR spectroscopy and that obtained with dual-energy CT (r

60 ty improved to 87.5% with the addition of 1H MR spectroscopy and to 100% with the further addition of

61 This classification also predicted fMRI, MR spectroscopy and volumetry changes between groups.

62 ed 54 subjects who underwent antemortem (1)H MR spectroscopy and were clinically healthy or had AD-ty

63 s determined with proton magnetic resonance (MR) spectroscopy and ADC determined with diffusion MR im

64 Imaging studies such as magnetic resonance (MR) spectroscopy and diffusion tensor imaging have prove

65 rd deviation]) underwent magnetic resonance (MR) spectroscopy and MR imaging to assess hepatic trigly

66 years +/- 6.2) underwent magnetic resonance (MR) spectroscopy and MR imaging to assess hepatic trigly

67 Cardiac (31)P magnetic resonance (MR) spectroscopy and MR imaging, echocardiography, and c

68 hy (CSM) by using proton magnetic resonance (MR) spectroscopy and to evaluate white matter integrity

69 MR imaging, hydrogen 1 ((1)H) MR spectroscopy, and (13)C MR spectroscopy were performe

70 w-up until September 27, 2020.3T MR imaging, MR spectroscopy, and diffusion tensor imaging.

71 ed MR sequences (perfusion-weighted imaging, MR spectroscopy, and diffusion-tensor imaging) were perf

72 CSAmax, T2 from MR imaging and MR spectroscopy, and lipid fraction were consistent acro

73 sonance imaging (MRI), proton and phosphorus MR spectroscopy, and multiparametric liver MR, including

74 e combined MR protocol of DCE MR imaging, 1H MR spectroscopy, and perfusion MR imaging has high sensi

75 We applied a combination of fMRI, MR spectroscopy, and psychophysics to substantiate the l

76 ingle ((1)H) and multi-nuclear (e.g., (31)P) MR spectroscopy, and quantitative MR techniques for asse

77 psy, digital rectal examination, MR imaging, MR spectroscopy, and salvage radical prostatectomy with

78 cancer, their study by hyperpolarized (13)C MR spectroscopy, and the development of new platforms fo

79 t PCC and healthy control participants using MR spectroscopy, and to investigate the relationship bet

80 Finally, the use of MRI, MR spectroscopy, and ultrasound as possible alternative

81 nt in vivo proton ((1)H) magnetic resonance (MR) spectroscopy, and postmortem frontal lobe tissue was

82 ower extremity muscles by using MRI and (1)H MR spectroscopy; and correlate upper extremity MRI and (

83 MR spectroscopy appears to be less specific (78%) than t

84 essive encephalopathy in children with AIDS, MR spectroscopy appears to be more sensitive and specifi

85 east lesions, independent from the technical MR spectroscopy approach.

86 Background Upper extremity MRI and proton MR spectroscopy are increasingly considered to be outcom

87 /Cr values determined at single-voxel proton MR spectroscopy are more sensitive than are standard fin

88 SPECT, PET, and MR spectroscopy are the most commonly used imaging techn

89 sions of unknown histologic type, the use of MR spectroscopy as an adjunct to MR imaging would have s

90 quantify fat over the entire liver, by using MR spectroscopy as the reference standard, when T2 corre

91 H-1 MR spectroscopy at 0.5 T provides clinically useful info

92 relative to water were measured with proton MR spectroscopy at 1.5 and 7 T.

93 their noncodeleted counterparts measured by MR spectroscopy at 3.0 T with a point-resolved spectrosc

94 2 agonist, using surface-coil localized (2)H MR spectroscopy at 7 T.

95 thy matched control subjects underwent (31)P MR spectroscopy at 7 T.

96 hted MR imaging and three-dimensional proton MR spectroscopy at spatial resolution less than a cubic

97 of phosphorus 31 ((31)P) magnetic resonance (MR) spectroscopy at 7 T improves precision in cardiac me

98 ing a first visit, the subjects underwent 1H MR spectroscopy before and after being repositioned in t

99 ety-nine men who underwent endorectal MR and MR spectroscopy before external-beam radiation therapy f

100 only on those lesions with a choline peak at MR spectroscopy, biopsy may have been spared in 23 (58%)

101 ith positive choline findings at proton (1H) MR spectroscopy, biopsy might have been avoided for 17 (

102 modal MRI (fMRI go/no-go task, volumetry and MR spectroscopy), blood (inflammatory cytokines) and sto

103 Two patients underwent MR spectroscopy but declined to undergo perfusion MR ima

104 rrhotics demonstrated significant changes on MR spectroscopy but not on fMRI or volumetry.

105 o study glycogen metabolism in vivo is (13)C MR spectroscopy, but this technology is not routinely av

106 derwent hydrogen 1((1)H) magnetic resonance (MR) spectroscopy by using a point-resolved spatially loc

107 H-1 MR spectroscopy can be used to image and noninvasively q

108 MR spectroscopy can be used to study new tumor tissue ma

109 Spatially localized H-1 MR spectroscopy can provide sufficient sensitivity and s

110 Herein, we show that magnetic resonance (MR) spectroscopy can be used to measure oocyte water exc

111 rbon 13 ((13)C)-pyruvate magnetic resonance (MR) spectroscopy, can serve as indicators of response in

112 ncentration Evolution During Hemodialysis by MR Spectroscopy (CIPHEMO), NCT03119818.

113 Prior to MR spectroscopy, conventional MR imaging was performed a

114 With use of linear discriminant analysis of MR spectroscopy data alone, 92% of the frontotemporal de

115 (1)H-MR spectroscopy data were acquired using a GSH-optimized

116 Single-voxel MR spectroscopy data were collected from a single rectan

117 All MR spectroscopy data were postprocessed at a separate in

118 a that closely agree and correlate with (1)H MR spectroscopy data.

119 H-1 MR spectroscopy demonstrated biochemical abnormalities i

120 Conclusion MR spectroscopy-derived PDFF is superior to CAP in detec

121 Other methods, like perfusion CT, xenon CT, MR spectroscopy, diffusion weighted MRI and functional M

122 vel techniques including magnetic resonance (MR) spectroscopy, diffusion weighted MR, and MR elastogr

123 = 2170) utilizing proton magnetic resonance (MR) spectroscopy, dual-energy x-ray absorptiometry, and

124 nd pH as detected by 31P magnetic resonance (MR) spectroscopy during isometric exercise and recovery.

125 rametric MR imaging (T2-weighted MR imaging, MR spectroscopy, dynamic contrast-enhanced MR imaging) o

126 ith quantitative MR imaging and single-voxel MR spectroscopy, each within a single breath hold.

127 rial reaction time task, magnetic resonance (MR) spectroscopy estimates of sensorimotor GABA were acq

128 iffusion-weighted MR imaging was normal, and MR spectroscopy excluded acute demyelination or tissue n

129 (31)P-MR spectroscopy experiments showed that during inotropic

130 sing quantitative T2 MRI (P < .001) and (1)H MR spectroscopy fat fraction (P < .05).

131 on, rho = -0.49 to -0.70 [P < .01]) and (1)H MR spectroscopy fat fraction (rho = -0.64 to -0.71; P <

132 measures of agreement between MR imaging and MR spectroscopy fat fraction measurements, to determine

133 ansverse relaxation time constant; MRI-T2 ), MR spectroscopy (fat fraction and (1) H2 O T2 ), and 6-m

134 Outcome on the basis of proton MR spectroscopy findings combined with clinical data and

135 MR spectroscopy findings were defined as positive if the

136 MR spectroscopy findings were then compared with histolo

137 nalysis-with admission clinical data, proton MR spectroscopy findings, and MR imaging score (three-po

138 MR signal intensity abnormalities, ADCs, 1H MR spectroscopy findings, and relaxation times were comp

139 d when combined with prior longitudinal (1)H MR spectroscopy findings, indicate that these measuremen

140 excellent correlation between MR imaging and MR spectroscopy for all reconstruction combinations.

141 -voxel MR spectroscopy or spatially resolved MR spectroscopy for differentiation between benign and m

142 s were reviewed in 78 patients who underwent MR spectroscopy for evaluation of a focal brain mass sus

143 g, dynamic contrast-enhanced MR imaging, and MR spectroscopy for peripheral zone tumors was examined

144 proton (hydrogen 1 [1H]) magnetic resonance (MR) spectroscopy for diagnosing malignant enhancing nonm

145 Proton (1H) MR spectroscopy had 100% sensitivity and 85% specificity

146 In two (3%) patients, MR spectroscopy had a potential negative influence.

147 resent a summary of brain disorders in which MR spectroscopy has an impact on patient management, tog

148 The clinical usefulness of (1)H MR spectroscopy has been established for brain neoplasms

149 MR spectroscopy has demonstrated the first example of in

150 In vivo 3-T MR spectroscopy has sufficient spatial resolution and ch

151 oton (hydrogen 1 [(1)H]) magnetic resonance (MR) spectroscopy has evolved from a research tool into a

152 Magnetic resonance (MR) spectroscopy has shown promise in the evaluation of

153 MRI and localized MR spectroscopy have been demonstrated as noninvasive me

154 n-tensor imaging, functional MR imaging, and MR spectroscopy have yielded findings that provide tangi

155 Findings at proton MR spectroscopy helped predict long-term neurologic outc

156 MRI and MR spectroscopy imaging were consistent with a hypomyeli

157 onance imaging and liver fat content by (1)H-MR spectroscopy in 449 individuals at risk for type 2 di

158 Proton MR spectroscopy in a clinical MR imager was used to asce

159 MR spectroscopy in eight (16%) patients with positive fi

160 ies, T1, and T2 were measured with localized MR spectroscopy in potential BAT and in subcutaneous WAT

161 chronic spinal cord injury (SCI) by applying MR spectroscopy in the cervical spinal cord.

162 The article documents the impact of (1)H MR spectroscopy in the clinical evaluation of disorders

163 with diffusion-weighted magnetic resonance (MR) spectroscopy in vivo and comparing it to the diffusi

164 ge part of the region of interest studied at MR spectroscopy included the basal ganglia.

165 or imaging indices of tissue microstructure, MR spectroscopy indices of neuronal density, arterial sp

166 1H MR spectroscopy is feasible for repeatable quantificatio

167 Conclusion 7-T cardiac (31)P MR spectroscopy is feasible in patients with DCM and giv

168 ricular balloon, energetics by (31)P nuclear MR spectroscopy, lactate and creatine kinase release spe

169 In addition, the MR spectroscopy marker of neuronal viability, N-acetylas

170 tor-gated and gradient-echo shimmed PRESS 1H MR spectroscopy may allow quantification of liver metabo

171 Proton MR spectroscopy may be a more sensitive diagnostic techn

172 f pyruvate to lactate as detected with (13)C-MR spectroscopy may be indicative of the presence of inf

173 In summary, MR imaging and MR spectroscopy may be more sensitive than sextant biops

174 The growing list of disorders for which (1)H MR spectroscopy may contribute to patient management ext

175 MR spectroscopy may play a beneficial role in the manage

176 s suggest that hyperpolarized (13)C-pyruvate MR spectroscopy may serve as an early indicator of respo

177 MR spectroscopy measurements revealed no group differenc

178 uisition, or qualitative versus quantitative MR spectroscopy measurements were identified.

179 uiring upper extremity MRI and proton ((1)H) MR spectroscopy measures of T2 and fat fraction in a lar

180 ; and correlate upper extremity MRI and (1)H MR spectroscopy measures to function.

181 ial energy metabolism was tested using (31)P MR spectroscopy, measuring PCr/ATP ratios in both groups

182 f a large-scale population-based cohort with MR spectroscopy (MEGA-PRESS) and resting-state fMRI.

183 Antemortem (1)H MR spectroscopy metabolite changes correlated with AD-ty

184 The study findings validated (1)H MR spectroscopy metabolite measurements against the neur

185 y investigated the associations between (1)H MR spectroscopy metabolite measurements and Braak neurof

186 ecommendations to expedite the use of robust MR spectroscopy methodology in the clinical setting, inc

187 d clinical acceptance and standardization of MR spectroscopy methodology, guidelines are provided for

188 models.Keywords: Animal Studies, MR-Imaging, MR-Spectroscopy, Molecular Imaging-Cancer, Molecular Ima

189 f tumor pH by pH-sensitive PET radiotracers, MR spectroscopy, MRI, and optical imaging.

190 t these hypotheses, hyperpolarized (13)C-DHA MR spectroscopy (MRS) and (18)F-FDG PET were applied as

191 Proton MR spectroscopy (MRS) and 8-point Dixon MR imaging (MRI)

192 MR spectroscopy (MRS) changes of increased Glutamate/glu

193 terature presenting the results of series of MR spectroscopy (MRS) examinations in the course of BBE.

194 uoroethyl)-l-tyrosine ((18)F-FET) and proton MR spectroscopy (MRS) imaging of cell turnover measured

195 line levels can be detected by proton ((1)H) MR spectroscopy (MRS) in vivo, whereas active (dynamic)

196 MR spectroscopy (MRS) is a noninvasive imaging method en

197 this, single volume localized in vivo proton MR spectroscopy (MRS) studies of the left and right hipp

198 structural magnetic resonance imaging (MRI), MR spectroscopy (MRS), and diffusion weighted imaging (D

199 s, and the contribution of cerebral CT, MRI, MR spectroscopy (MRS), positron emission tomography (PET

200 -fraction (PDFF), as well as by conventional MR spectroscopy (MRS).

201 uctural magnetic resonance imaging (MRI) and MR spectroscopy (MRS).

202 scuss the findings in perfusion MR (PWI) and MR spectroscopy (MRS).

203 uracy of thalamic proton magnetic resonance (MR) spectroscopy (MRS) biomarkers as early predictors of

204 shift-based techniques such as single-voxel MR spectroscopy, multipoint water-fat separation, and MR

205 amic contrast-enhanced imaging (n = 51), and MR spectroscopy (n = 91).

206 es were analyzed for regional 39K content by MR spectroscopy (n=9), K+ and Na+ concentrations by atom

207 diagnosis of breast cancer.Keywords: Breast, MR-Spectroscopy, Neoplasms-Primary(C) RSNA, 2020.

208 Keywords: MR Spectroscopy, Neural Networks, Brain/Brain Stem Suppl

209 Keywords: Molecular Imaging, MR Perfusion, MR Spectroscopy, Neuro-Oncology, PET/CT, SPECT/CT, Head/

210 gated by using high-spectral-resolution (1)H MR spectroscopy of brain extracts.

211 High resolution MR spectroscopy of brain metabolites revealed significan

212 Longitudinal T2-weighted MR imaging, dynamic MR spectroscopy of hyperpolarized pyruvate, and (18)F-FD

213 al features of MELAS syndrome in CT, MRI and MR spectroscopy of the brain and differential diagnosis.

214 s gave written informed consent, proton (1H) MR spectroscopy of the breast was performed in suspiciou

215 I measures, obtained using single-voxel (1)H-MR spectroscopy of the cervical cord and diffusion-based

216 viation, 43 years +/- 13) underwent 3-T (1)H MR spectroscopy of the L2 vertebra by using a point-reso

217 ent 3.0-T single-voxel point-resolved proton MR spectroscopy of the liver (segment VII) to calculate

218 Extracellular pH-specific MR spectroscopy of untreated liver tumors showed acidosi

219 ubjects underwent proton magnetic resonance (MR) spectroscopy of the second lumbar vertebra to evalua

220 ong echo time (272 msec) proton (hydrogen 1) MR spectroscopy on a 4 x 2 x 2-cm voxel in the basal gan

221 ive studies are needed to test the effect of MR spectroscopy on clinical practice and to measure cost

222 greatly enhanced sensitivity to multinuclear MR spectroscopy, opening up a new tool with which to non

223 3.0 T applying one-dimensional single-voxel MR spectroscopy or spatially resolved MR spectroscopy fo

224 Single-voxel quantitative (1)H MR spectroscopy performed in patients with untreated ped

225 ing, functional MR imaging, MR elastography, MR spectroscopy, perfusion-weighted imaging, MR imaging

226 vivo skeletal muscle oxidative capacity via MR spectroscopy (post-exercise recovery rate, k(PCr)) is

227 cluded 14 patients who underwent in vivo 3-T MR spectroscopy prior to stereotactic biopsy.

228 ate Cancer, Neural Networks, Histopathology, MR-Spectroscopy, Prostate, Tissue Characterization, Tech

229 The combined MR imaging-MR spectroscopy protocol was performed in 50 patients af

230 g, dynamic contrast-enhanced MR imaging, and MR spectroscopy provided significant independent and add

231 se To study fat depots with localized proton MR spectroscopy relaxometry and to identify differences

232 The addition of 1H MR spectroscopy resulted in higher sensitivity, specific

233 MR spectroscopy results from BAT and WAT were compared w

234 lassified as recurrent tumor on the basis of MR spectroscopy results, was diagnosed as predominantly

235 the ipsilateral corticospinal tract, whereas MR spectroscopy showed absence of normal brain metabolit

236 MR imaging and MR spectroscopy showed estimated sensitivities of 68% an

237 Conclusion Proton MR spectroscopy showed shorter T2 and lower unsaturated

238 Similarly, 23Na MR spectroscopy showed that [Na+] was higher in nonviabl

239 Noninvasive (31)P MR spectroscopy showed that the nucleoside triphosphate/

240 Breast MR spectroscopy shows variable sensitivity and high spec

241 y acquired BOLD-fMRI and single voxel proton MR spectroscopy signals were measured in V1 of 24 health

242 ate signals in the early visual cortex using MR spectroscopy.SIGNIFICANCE STATEMENT Glutamate and GAB

243 Keywords: MR Spectroscopy, Spectroscopic Imaging, Molecular Imagin

244 etization transfer, T2 decay-curve analysis, MR spectroscopy, spinal cord imaging, diffusion imaging,

245 Based on previous magnetic resonance (MR) spectroscopy studies demonstrating relationships bet

246 Quantitative 1H MR spectroscopy, T1, and T2 data were acquired on one 10

247 ine, "functional" imaging techniques such as MR spectroscopy, T1rho calculation, T2 relaxation time m

248 th percentile, 1.2%; 75th percentile, 4.7%]; MR spectroscopy T2, CV = 3.9% [25th percentile, 1.5%; 75

249 Particularly helpful are the MRI and MR spectroscopy techniques.

250 s were compared with results of liver proton MR spectroscopy, the reference standard.

251 Keywords: MR Imaging, MR Spectroscopy, Thorax, Lung, Hyperpolarized (129)Xe, M

252 to assess bone density and strength, proton MR spectroscopy to assess BMAT (L1 and L2 levels), and M

253 strated the feasibility of performing proton MR spectroscopy to assess mobile fetal structures.

254 MR imaging, perfusion MR imaging, and proton MR spectroscopy to classify intraaxial masses as low-gra

255 We used (31)P MR spectroscopy to determine the relationship between my

256 aging and three-dimensional 3-T voxel proton MR spectroscopy to measure absolute rostral and caudal A

257 cognitive control whilst undergoing fMRI and MR spectroscopy to measure glutamate levels from Anterio

258 s erythematosus (SLE) were examined with H-1 MR spectroscopy to measure N-acetylaspartate (NAA), crea

259 -echo MR imaging, multi-echo MR imaging, and MR spectroscopy to quantify fatty degeneration of bilate

260 suggest that the addition of quantitative 1H MR spectroscopy to the breast MR imaging examination may

261 ) and showed the feasibility of MRI and (1)H MR spectroscopy to track disease progression over a wide

262 ut also for magnetic resonance (MR) imaging, MR spectroscopy, ultrasonography, and the emerging field

263 because of unfavorable lesion morphology for MR spectroscopy voxel placement.

264 y receiver operating characteristic curve of MR spectroscopy was 0.88, and the Q* index was 0.81.

265 ve findings with subsequently proved tumors, MR spectroscopy was classified as having a potential neg

266 dically or followed up for interval changes, MR spectroscopy was classified as having a potential pos

267 t Dorsolateral Prefrontal Cortex (DLPFC) and MR Spectroscopy was collected before and after intervent

268 The accuracy of T2-corrected MR spectroscopy was evaluated in eight lipid phantoms do

269 Proton nuclear MR spectroscopy was first performed to identify lipiodol

270 chnique using high-spatial-resolution proton MR spectroscopy was modified and used to examine the uti

271 Single-voxel localized proton MR spectroscopy was performed at 0.5 T in 18 patients (a

272 In a prospective study, (31)P MR spectroscopy was performed at 3 T and 7 T in 25 patie

273 gle-voxel point-resolved proton (hydrogen 1) MR spectroscopy was performed from a 2-cm(3) voxel cente

274 MR spectroscopy was performed in 19 subjects preoperativ

275 ained for this HIPAA-compliant study, breast MR spectroscopy was performed in patients with suspiciou

276 mulated-echo acquisition mode, or STEAM, H-1 MR spectroscopy was performed to determine the concentra

277 MR spectroscopy was performed using a 3-T MRI system, me

278 gravidas at 38 and 39 weeks gestation, fetal MR spectroscopy was performed with a breath-hold techniq

279 Proton MR spectroscopy was successfully incorporated into breas

280 Single-voxel T2-corrected MR spectroscopy was used to measure fat fraction and ser

281 (31)P magnetic resonance (MR) spectroscopy was used to measure cardiac phosphocrea

282 Proton (hydrogen 1) magnetic resonance (MR) spectroscopy was used to study model and porcine bil

283 al-enhanced [DCE] MR imaging, and hydrogen 1 MR spectroscopy) was performed with a 3.0-T wholebody MR

284 r-referenced localized phosphorus and proton MR spectroscopy were combined in a single protocol to no

285 Fat fractions measured with MR imaging and MR spectroscopy were compared statistically to determine

286 digital rectal examination, MR imaging, and MR spectroscopy were determined by using a prostate sext

287 hydrogen 1 ((1)H) MR spectroscopy, and (13)C MR spectroscopy were performed at 1.5 T in 10 subjects,

288 animal study, anatomic MRI and dynamic (13)C MR spectroscopy were performed at 7 T during intravenous

289 MR imaging and H-1 MR spectroscopy were performed in 14 patients with front

290 ial-enhanced MR imaging and single-voxel H-1 MR spectroscopy were performed in 17 patients (age range

291 s (T2*) as well as spectral parameters using MR Spectroscopy were performed in a 3 T MR scanner durin

292 Anatomic MRI and dynamic (13)C MR spectroscopy were repeated after administration of th

293 rn blot), HEP levels, and CK kinetics ((31)P MR spectroscopy) were measured under basal conditions.

294 rwent both brain MR imaging and single-voxel MR spectroscopy with a long-echo-time point-resolved tec

295 d diffusion-weighted cerebral MR imaging, 1H MR spectroscopy with absolute quantification, and T1 and

296 model of severe TBI and magnetic resonance (MR) spectroscopy with infusion of (13)C-labeled glucose,

297 FF) obtained with proton magnetic resonance (MR) spectroscopy with results of liver biopsy in a cohor

298 It was feasible to identify BAT with MR spectroscopy without the use of PET/CT or cold stimul

299 ith unknown histologic features, proton (1H) MR spectroscopy would have significantly (P<.01) increas

300 MR spectroscopy yielded a total creatine value of 36.2 m